| Authors: |
Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA., Blais EM; Perthera, Inc, McLean, VA., Wolpin B; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, TX., Collisson E; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Singh I; Memorial Sloan Kettering Cancer Center, New York, NY., Cannon T; Inova Schar Cancer Institute, Fairfax, VA., Shaw K; The University of Texas MD Anderson Cancer Center, Houston, TX., Petricoin EF 3rd; George Mason University, Perthera, Inc, Fairfax, VA., Klempner S; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Lyons E; Pancreatic Cancer Action Network, Manhattan Beach, CA., Wang-Gillam A; Washington University School of Medicine, St Louis, MO., Pishvaian MJ; Johns Hopkins University School of Medicine, Perthera Inc, McLean, VA., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY. |
